The effect of intraprostatic chronic inflammation on benign prostatic hyperplasia treatment

Korean Journal of Urology

Volumn 51, Issue 4, 2010, Pages 266-270

  Kwon, Young Kee ^a   Choe, Mi Sun ^b   Seo, Kyung Won ^a   Park, Chol Hee ^a   Chang, Hyuk Soo ^a   Kim, Byung Hoon ^a   Kim, Chun Il ^a  

^a Dongsan Medical Center   (South Korea)

^b Keimyung University School of Medicine   (South Korea)

Author keywords

Diagnosis; Inflammation; Prostatic hyperplasia

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; ARTICLE; CHRONIC DISEASE; HUMAN; INFLAMMATION; INTERNATIONAL PROSTATE SYMPTOM SCORE; MAJOR CLINICAL STUDY; MALE; NEEDLE BIOPSY; PATHOLOGIST; PROSTATE; PROSTATE BIOPSY; PROSTATE HYPERTROPHY; PROSTATE SURGERY; QUALITY OF LIFE; SCORING SYSTEM; TRANSRECTAL ULTRASONOGRAPHY;

EID: 77951656146     PISSN: 20056737     EISSN: 20056745     Source Type: Journal    
DOI: 10.4111/kju.2010.51.4.266     Document Type: Article

References (21)

1. Djavan B, Fong YK, Harik M, Milani S, Reissigl A, Chaudry A, et al. Longitudinal study of men with mild symptoms of bladder outlet obstruction treated with watchful waiting for four years. Urology 2004;64:1144-1148
2. Crawford ED, Wilson SS, McConnell JD, Slawin KM, Lieber MC, Smith JA, et al. Baseline factors as predictors of clinical progression of benign prostatic hyperplasia in men treated with placebo. J Urol 2006;175:1422-1426
3. Roehrborn CG, Kaplan SA, Noble WD, Lucia MS, Slawin KM, McVary KT, et al. The impact of acute or chronic inflammation in baseline biopsy on the risk of clinical progression of BPH: results from the MTOPS study. J Urol 2005;173(Suppl):346, abstract 1277.
4. Mishra VC, Allen DJ, Nicolaou C, Sharif H, Hudd C, Karim OM, et al. Does intraprostatic inflammation have a role in the pathogenesis and progression of benign prostatic hyperplasia? BJU Int 2007;100:327-331
5. Kefi A, Koseoglu H, Celebi I, Yorukoglu K, Esen A. Relation between acute urinary retention, chronic prostatic inflammation and accompanying elevated prostate-specific antigen. Scand J Urol Nephrol 2006;40:155-160
6. Tuncel A, Uzun B, Eruyar T, Karabulut E, Seckin S, Atan A. Do prostatic infarction, prostatic inflammation and prostate morphology play a role in acute urinary retention? Eur Urol 2005;48:277-283
7. Ha JY, Kwak DY, Chang HS, Park CH, Kwon SY, Kim CI. Relationship between acute urinary retention and intraprostatic inflammation in benign prostatic hyperplasia. Korean J Urol 2008;49:1081-1086
8. Irani J, Levillain P, Goujon JM, Bon D, Dore B, Aubert J. Inflammation in benign prostatic hyperplasia: correlation with prostate specific antigen value. J Urol 1997;157:1301-1303
9. Kohnen PW, Drach GW. Patterns of inflammation in prostatic hyperplasia: a histologic and bacteriologic study. J Urol 1979;121:755-760
10. Nickel JC, Roehrborn CG, O'Leary MP, Bostwick DG, Somerville MC, Rittmaster RS. The relationship between prostate inflammation and lower urinary tract symptoms: examination of baseline data from the REDUCE trial. Eur Urol 2008;54:1379-1384
11. Nickel JC. Prostatic inflammation in benign prostatic hyperplasia-the third component? Can J Urol 1994;1:1-4.
12. Kang TW, Oh BR, Kim KW, Min KD, Kwon DD, Ryu SB. Clinical significance of prostatitis in patients with benign prostatic hyperplasia. Korean J Urol 2003;44:278-282
13. Schaeffer AJ. Evaluation of the cytokines in genital secretions of patients with chronic prostatitis. J Urol 2005;173:844-845
14. Miller LJ, Fischer KA, Goralnick SJ, Litt M, Burleson JA, Albertsen P, et al. Nerve growth factor and chronic prostatitis/chronic pelvic pain syndrome. Urology 2002;59:603-608
15. Orhan I, Onur R, Ilhan N, Ardiçoglu A. Seminal plasma cytokine levels in the diagnosis of chronic pelvic pain syndrome. Int J Urol 2001;8:495-499
16. Nickel JC, Downey J, Young I, Boag S. Asymptomatic inflammation and/or infection in benign prostatic hyperplasia. BJU Int 1999;84:976-981
17. Collins MM, Meigs JB, Barry MJ, Walker Corkery E, Giovannucci E, Kawachi I. Prevalence and correlates of prostatitis in the health professionals follow-up study cohort. J Urol 2002;167:1363-1366
18. Nickel JC. Inflammation and benign prostatic hyperplasia. Urol Clin North Am 2008;35:109-115
19. Ozdemir I, Bozkurt O, Demir O, Aslan G, Esen AA. Combination therapy with doxazosin and tenoxicam for the management of lower urinary tract symptoms. Urology 2009;74:431-435
20. Di Silverio F, Bosman C, Salvatori M, Albanesi L, Proietti Pannunzi L, Ciccariello M, et al. Combination therapy with rofecoxib and finasteride in the treatment of men with lower urinary tract symptoms (LUTS) and benign prostatic hyperplasia (BPH). Eur Urol 2005;47:72-78
21. Minnery CH, Getzenberg RH. Benign prostatic hyperplasia cell line viability and modulation of jm-27 by doxazosin and ibuprofen. J Urol 2005;174:375-379